Sigyn Therapeutics Inc 's Cash & cash equivalent grew by 18542.92 % in the Q3 2025 sequentially, while Current Liabilities decreased, this led to improvement in Sigyn Therapeutics Inc 's Quick Ratio to 0.02, Quick Ratio remained below Sigyn Therapeutics Inc average.

Within Medical Equipment & Supplies industry 216 other companies have achieved higher Quick Ratio than Sigyn Therapeutics Inc in third quarter 2025. While Quick Ratio total ranking has improved so far during the Q3 2025 to 5119, from total ranking in the second quarter 2025 at 5568.

Explain Quick Ratio?
How much Cash & cash equivalents RSAP�s has?
What are RSAP�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RSAP Quick Ratio	(Sep 30 2025) Q3	(Jun 30 2025) Q2	(Mar 31 2025) Q1	(Dec 31 2024) Q4	(Sep 30 2024) Q3
Y / Y Current Liabilities Change	-6.68 %	40.77 %	21.66 %	27.91 %	15.09 %
Y / Y Cash & cash equivalent Change	-48.07 %	-99.14 %	-60.73 %	3.88 %	155.09 %
Quick Ratio MRQ	0.02	0	0	0	0.04
RSAP's Total Ranking	# 5119	# 5568	# 5510	# 5889	# 5051
Seq. Current Liabilities Change	-27.32 %	6.55 %	11.64 %	7.95 %	9.63 %
Seq. Cash & cash equivalent Change	18542.92 %	-96.44 %	6.18 %	-92.63 %	207.19 %

Quick Ratio third quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 217
Healthcare Sector	# 1015
Overall Market	# 5024

Quick Ratio Statistics
High	Average	Low
1.46	0.1	0
(Jun 30 2021)		(Jun 30 2025)

Financial Statements
Sigyn Therapeutics Inc 's Current Liabilities	$ 4 Millions	Visit RSAP's Balance sheet
Sigyn Therapeutics Inc 's Cash & cash equivalent	$ 0 Millions	Visit RSAP's Balance sheet
Source of RSAP's Sales		Visit RSAP's Sales by Geography

Cumulative Sigyn Therapeutics Inc 's Quick Ratio

RSAP's Quick Ratio for the trailling 12 Months

RSAP Quick Ratio	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months	(Mar 31 2025) 12 Months	(Dec 31 2024) 12 Months	(Sep 30 2024) 12 Months
Y / Y Current Liabilities TTM Growth	20.15 %	26.36 %	21.2 %	27.56 %	36.5 %
Y / Y Cash & cash equivalent TTM Growth	-57.76 %	16.9 %	83.39 %	-37.62 %	-37.23 %
Quick Ratio TTM	0.01	0.01	0.01	0.02	0.02
Total Ranking TTM	# 3109	# 3126	# 3474	# 0	# 3514
Seq. Current Liabilities TTM Growth	-1.46 %	8.86 %	5.39 %	6.29 %	3.63 %
Seq. Cash & cash equivalent TTM Growth	-41.63 %	-21.84 %	-7.57 %	0.17 %	61.55 %

Quick ratio ranking by company, industry and sector >> Back to RSAP Financial Strength Comparisons >> Go to Compare RSAP Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in RSAP's Current Liabilities to $3.99 millions, cumulative Quick Ratio to 0.01 below the RSAP average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Sigyn Therapeutics Inc . While Quick Ratio overall ranking has improved so far to 3109, from total ranking during the twelve months ending second quarter 2025 at 3126.

Explain Quick Ratio?
How much Cash & cash equivalents RSAP�s has?
What are RSAP�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 194
Healthcare Sector	# 861
Within the Market	# 3109

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.64	0.09	0
(Dec 31 2021)		(Sep 30 2020)

Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2025 MRQ Cash & cash equivalent	Sep 30 2025 MRQ Current Liabilities
Enovis Corp	0.06	$ 33.617 Millions	$ 575.443 Millions
Infusystem Holdings Inc	0.05	$ 0.955 Millions	$ 18.718 Millions
Biotricity Inc	0.05	$ 1.181 Millions	$ 23.614 Millions
Yunhong Green Cti Ltd	0.05	$ 0.387 Millions	$ 8.241 Millions
Henry Schein Inc	0.04	$ 136.000 Millions	$ 3,068.000 Millions
Globus Medical Inc	0.04	$ 18.754 Millions	$ 465.958 Millions
Dror Ortho-Design, Inc.	0.04	$ 0.068 Millions	$ 1.727 Millions
Invo Fertility Inc	0.04	$ 0.356 Millions	$ 9.245 Millions
Mountain Crest Acquisition Corp V	0.02	$ 0.041 Millions	$ 1.837 Millions
Sigyn Therapeutics Inc	0.02	$ 0.086 Millions	$ 3.989 Millions
The Pennant Group Inc	0.02	$ 2.336 Millions	$ 109.352 Millions
Vsee Health Inc	0.02	$ 0.473 Millions	$ 23.422 Millions
Stimcell Energetics Inc	0.02	$ 0.006 Millions	$ 0.335 Millions
Baird Medical Investment Holdings Limited	0.02	$ 0.566 Millions	$ 32.364 Millions
Yubo International Biotech Limited	0.01	$ 0.037 Millions	$ 2.555 Millions
Vycor Medical Inc	0.01	$ 0.070 Millions	$ 5.553 Millions
Fonar Corporation	0.01	$ 0.122 Millions	$ 16.665 Millions
Non Invasive Monitoring Systems Inc	0.01	$ 0.006 Millions	$ 0.995 Millions
Premier Air Charter Holdings Inc	0.00	$ 0.064 Millions	$ 13.056 Millions

Date modified: 2026-09-08T15:11:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.